204
Views
74
CrossRef citations to date
0
Altmetric
Review

Rotavirus vaccine introduction in the Americas: progress and lessons learned

, , &
Pages 345-353 | Published online: 09 Jan 2014

References

  • Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and death caused by rotavirus disease in children. Emerging Infect. Dis.9(5), 565–572 (2003).
  • Parashar UD, Christopher JG, Bresee JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerging Infect. Dis.12(2), 304–306 (2006).
  • Pan American Health Organization. Experts meet in Mexico to discuss rotavirus. Immunization Newsletter26(5) (2004).
  • Kane EM, Turcios RM, Arway ML, Garcia S, Bresee JS, Glass RI. The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines. Rev. Panam. Salud Publica/Pan Am. J. Public Health16(6), 371–377 (2004).
  • Parashar UD, Holman RC, Bresee JS et al. Epidemiology of diarrheal disease among children enrolled in four West health maintenance organizations. Vaccine Safety Datalink Team. Pediatr. Infect. Dis. J.17, 605–611 (1998).
  • Centers for Disease Control and Prevention. Rotavirus. In: The Pink Book (10th Edition). Washington, DC, USA 20, 295–305 (2007).
  • Clark HF, Offit PA, Glass RI. In: Vaccines (4th Edition). Orenstein WA, Plotkin SA (Eds). Elsevier Inc, Philadelphia, PA, USA, 1327–1355 (2004).
  • Organización Panamericana de la Salud. In: Vigilancia epidemiológica de diarreas causadas por rotavirus: guía práctica. Publicación Científica y Técnica, Washington, DC, USA, Number 623 (2007).
  • CDC. Withdrawal of rotavirus vaccine recommendation. MMWR Morb. Mortal. Wkly Rep.48(43), 1007 (1999).
  • Murphy TV, Gargiullo PM, Massoudi MS et al. Rotavirus Intussusception Investigation Team. Intussusception among infants given an oral rotavirus vaccine. N. Engl. J. Med.344(8), 564–572 (2001). Erratum in: N. Engl. J. Med.344(20) 1564– (2001).
  • WHO. Rotavirus vaccine, WHO position paper. Wkly Epidemiol. Rec.82(32), 285–296 (2007).
  • Palacios GM, Perez-Schael I, Velasques RF et al. Safety and Efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med.354(1), 11–22 (2006).
  • Vesikari T, Matson DO, Dennehy P et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med.354(1), 23–33 (2006).
  • O’Ryan M. Rotarix™ (RIX4414): an oral human rotavirus vaccine. Expert Rev. Vaccines6(1), 11–19 (2007).
  • Cunliffe NA, Nakagomi O. A critical time for rotavirus vaccines: a review. Expert Rev. Vaccines4(4), 521–532 (2005).
  • Declaration by Representatives of Ministries of Heath of the Americas. Rotavirus and rotavirus vaccines. Proceedings of the Sixth International Rotavirus Symposium. Mexico City, Mexico, 7–9 July 2004 (Abstract 37).
  • Castillo-Solórzano C, Andrus J, Periago MR. El desarrollo de nuevas vacunas: generacion de información para la toma de decisiones. Rev. Panam. Salud Publica/Pan Am. J. Public Health15(1), 1–3 (2004).
  • Andrus JK, Tambini G, di Fabio JL, Periago MR. Anticipating new vaccines in the Americas. Rev. Panam. Salud Publica/Pan Am. J. Public Health16(6), 369–370 (2004).
  • Pan American Health Organization. Resolution CD47.R10. 47th Directing Council, Washington, DC, USA (2006).
  • World Health Organization. Global Immunization Vision and Strategy, 2006–2015. WHO/IVB/05.05. Geneva, Switzerland (2005).
  • Andrus JK, Fitzsimmons J, de Quadros CA. Introduction of new vaccines and underutilized vaccines: perspective from the Americas. In: Recent Advances in Immunization (2nd Edition). Pan American Health Organization, Washington, DC, USA Scientific Publication Number 619, 114–126 (2006).
  • Pan American Health Organization. XVII Meeting of the Technical Advisory Group on Vaccine-preventable Diseases. Final Report. Guatemala City, Guatemala, 25 (2006).
  • Andrus JK, Toscano C, Lewis M et al. A model for enhancing evidenced-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO’s Pro-Vac initiative. Public Health Rep.122(6), 811–816 (2007).
  • Pan American Health Organization. Multiyear project proposal for the promotion of evidence-based policy decisions for new vaccine introduction in Latin America and the Caribbean (Pro-Vac). Immunization Newsletter28(5) (2006).
  • Bresee JS, Hummelman E, Nelson EA, Glass RI. Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines. J. Infect. Dis.192(S1), 5 (2005).
  • Bok K, Palacios G, Sijvarger K, Matson D, Gomez J. Emergence of G9 P[6] human rotaviruses in Argentina: phylogenetic relationships among G9 strains. J. Clin. Microbiol.39(11), 4020–4025 (2001).
  • Parra GI, Bok K, Martínez V, Russomando G, Gómez J. Molecular characterization and genetic variation of the VP7 gene of human rotaviruses isolated in Paraguay. J. Med. Virol.77(4), 579–586 (2005).
  • Bucardo F, Karlsson B, Nordgren J et al. Mutated G4P[8] rotavirus associated with a nationwide outbreak of gastroenteritis in Nicaragua in 2005. J. Clin. Microbiol.45(3), 990–997 (2007).
  • Centers for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.55(RR-12) (2006).
  • Dayan GH, Shaw KM, Baughman AL et al. Assessment of delay in age-appropriate vaccination using survival analysis. Am. J. Epidemiol.163(6), 561–570 (2006).
  • Pan American Health Organization. Summary of EPI Evaluation in Uruguay, November 2006. Immunization Newsletter29(2) (2007).
  • Dietz V, Venczel L, Izurieta H et al. Assessing and monitoring vaccination coverage levels: lessons from the Americas. Rev. Panam. Salud Publica/Pan Am. J. Public Health16(6), 432–442 (2004).
  • PAHO’s Revolving Fund for vaccine procurement; Rotarix™ and RotaTeq™ package inserts.
  • Survey to National Immunization Programs, September-November, 2007.
  • Survey to National Immunization Programs, October–November, 2007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.